Chemical Dependency Program
D: Client here today to complete the intake process for enrolling in alcohol and drug treatment program at THS. Client was diagnosed with Severe Opioid use disorder F11.20, Severe Cannabis use disorder F12.20, and moderate Tobacco use disorder F17.200. Treatment recommendation is completion of 6 month intensive outpatient treatment. Assessment recommendation and treatment concerns were discussed, client stated that she would like to begin group on 04/03/2017. THS treatment program expectations, treatment logistics, and financial agreement were reviewed. Client was fully informed of consent to treatment. Counselor answered questions about treatment protocol. Treatment plan was developed, which is focused
D: Client here today to complete the intake process for enrolling in alcohol and drug treatment program at THS. Client was diagnosed with Severe Opioid use disorder F11.20, Severe Cannabis use disorder F12.20, and moderate Tobacco use disorder F17.200. Treatment recommendation is completion of 6 month intensive outpatient treatment. Assessment recommendation and treatment concerns were discussed, client stated that she would like to begin group on 04/03/2017. THS treatment program expectations, treatment logistics, and financial agreement were reviewed. Client was fully informed of consent to treatment. Counselor answered questions about treatment protocol. Treatment plan was developed, which is focused